Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI
Journal of the American Medical Informatics Association · 2023
DOI: 10.1093/jamia/ocad199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2023. Verfasst von Chan Joo Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Deep Learning, Coronary Artery Disease. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Health Technology Research and Development Project via Korea Health Industry Development Institute, Ministry of Health and Welfare, Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
Objective
The potential of using retinal images as a biomarker of cardiovascular disease (CVD) risk has gained significant attention, but regulatory approval of such artificial intelligence (AI) algorithms is lacking. In this regulated pivotal trial, we validated the efficacy of Reti-CVD, an AI-Software as a Medical Device (AI-SaMD), that utilizes retinal images to stratify CVD risk. Materials and Methods In this retrospective study, we used data from the Cardiovascular and Metabolic Diseases Etiology Research Center-High Risk (CMERC-HI) Cohort. Cox proportional hazard model was used to estimate hazard ratio (HR) trend across the 3-tier CVD risk groups (low-, moderate-, and high-risk) according to Reti-CVD in prediction of CVD events. The cardiac computed tomography-measured coronary artery calcium (CAC), carotid intima-media thickness (CIMT), and brachial-ankle pulse wave velocity (baPWV) were compared to Reti-CVD.
Results
A total of 1106 participants were included, with 33 (3.0%) participants experiencing CVD events over 5 years; the Reti-CVD-defined risk groups (low, moderate, and high) were significantly associated with increased CVD risk (HR trend, 2.02; 95% CI, 1.26-3.24). When all variables of Reti-CVD, CAC, CIMT, baPWV, and other traditional risk factors were incorporated into one Cox model, the Reti-CVD risk groups were only significantly associated with increased CVD risk (HR = 2.40 [0.82-7.03] in moderate risk and HR = 3.56 [1.34-9.51] in high risk using low-risk as a reference).
Discussion
This regulated pivotal study validated an AI-SaMD, retinal image-based, personalized CVD risk scoring system (Reti-CVD).
Conclusion
These results led the Korean regulatory body to authorize Reti-CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea.
- Ocular Epidemiology Research Group, Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 169856, Singapore.
- Mediwhale Inc, Seoul 08378, South Korea.
- Division of Retina, Severance Eye Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea.
- Department of Ophthalmology and Visual Science, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
- Food Functionality Research Division, Korea Food Research Institute, Wanju 55365, South Korea.
ORCID-Profile: Chan Joo Lee, Tyler Hyungtaek Rim, Marco Yu, Tien Yin Wong, Ching-Yu Cheng, Sungha Park
Förderung
- Korean Health Technology Research and Development Project via Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Korea Disease Control and Prevention Agency
- Main Research Program
- Korea Food Research Institute
- Korean Ministry of Science and ICT
- Korean Health Technology Research and Development
- Korea Health Industry Development Institute
Zitieren
APA
Lee, C. J., Rim, T. H., Kang, H. G., Yi, J. K., Lee, G., Yu, M., Park, S. H., Hwang, J. T., Tham, Y. C., Wong, T. Y., Cheng, C. Y., Kim, D. W., Kim, S. S., & Park, S. (2023). Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocad199
Vancouver
Lee CJ, Rim TH, Kang HG, Yi JK, Lee G, Yu M, et al. Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI. Journal of the American Medical Informatics Association. 2023. doi:10.1093/jamia/ocad199
BibTeX
@article{Lee2023,
author = {Lee, Chan Joo and Rim, Tyler Hyungtaek and Kang, Hyun Goo and Yi, Joseph Keunhong and Lee, Geunyoung and Yu, Marco and Park, Soo-Hyun and Hwang, Jin-Taek and Tham, Yih-Chung and Wong, Tien Yin and Cheng, Ching-Yu and Kim, Dong Wook and Kim, Sung Soo and Park, Sungha},
title = {Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI},
journal = {Journal of the American Medical Informatics Association},
year = {2023},
doi = {10.1093/jamia/ocad199}
}
EUVIMED